Latest News
Featured News
SCOPE readouts in sight; SCIB1 data in Q424
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
MHRA approval to add a third cohort using iSCIB1+ to the SCOPE trial
Result of 2023 Annual General Meeting
Update on SCOPE trial
Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial
Preliminary Results for the year ended 30 April 2023
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
